We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.17B
Cap. Flow
+$816M
Cap. Flow %
16.26%
Top 10 Hldgs %
31.54%
Holding
2,471
New
743
Increased
409
Reduced
522
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 10.94%
2 Financials 10.6%
3 Healthcare 8.31%
4 Industrials 7.75%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHT
1701
Ashford Hospitality Trust
AHT
$21.4M
-214
Closed -$154K
AIG icon
1702
American International
AIG
$40.1B
-11,296
Closed -$352K
AIZ icon
1703
Assurant
AIZ
$14.1B
-14,714
Closed -$1.52M
AL
1704
DELISTED
Air Lease Corp
AL
-18,115
Closed -$531K
ALEX
1705
DELISTED
Alexander & Baldwin
ALEX
-44,176
Closed -$539K
ALG icon
1706
Alamo Group
ALG
$2.01B
-2,585
Closed -$265K
ALLT icon
1707
Allot
ALLT
$363M
-12,200
Closed -$128K
ALT icon
1708
Altimmune
ALT
$597M
-23,400
Closed -$251K
ALV icon
1709
Autoliv
ALV
$9.18B
-9,407
Closed -$607K
AMCR icon
1710
Amcor
AMCR
$22.6B
-8,507
Closed -$434K
AME icon
1711
Ametek
AME
$54.7B
-2,712
Closed -$242K
AMG icon
1712
Affiliated Managers Group
AMG
$9.26B
-7,195
Closed -$536K
AMN icon
1713
AMN Healthcare
AMN
$1.33B
-6,454
Closed -$292K
AMPH icon
1714
Amphastar Pharmaceuticals
AMPH
$917M
-12,732
Closed -$286K
AMRN
1715
Amarin Corp
AMRN
$297M
-8,897
Closed -$1.23M
AMR icon
1716
Alpha Metallurgical Resources
AMR
$2.66B
-53,963
Closed -$164K
AMWD
1717
DELISTED
American Woodmark
AMWD
-9,579
Closed -$725K
ANDE icon
1718
Andersons Inc
ANDE
$2.29B
-14,954
Closed -$206K
ANIP icon
1719
ANI Pharmaceuticals
ANIP
$1.73B
-6,419
Closed -$208K
ANSS
1720
DELISTED
Ansys
ANSS
-2,057
Closed -$600K
AOSL icon
1721
Alpha and Omega Semiconductor
AOSL
$787M
-18,613
Closed -$203K
APEI icon
1722
American Public Education
APEI
$842M
-15,662
Closed -$464K
APPF icon
1723
AppFolio
APPF
$7.96B
-2,047
Closed -$333K
APPN icon
1724
Appian
APPN
$2.75B
-21,626
Closed -$1.11M
APT icon
1725
Alpha Pro Tech
APT
$53.6M
-11,775
Closed -$208K

Similar funds

Michael Gelband's Q3 2020 Portfolio in Review

As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.

  • Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
  • Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
  • Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
  • Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
  • Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
  • Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.